✦ LIBER ✦

**102 Chemoimmunotherapy with Ofatumumab, Fludarabine and Cyclophosphamide (O-FC) in Previously Untreated Patients with Chronic Lymphocytic Leukemia

✍ Scribed by William G. Wierda; Thomas J. Kipps; Jan Dürig; Laimonas Griskevicius; Stephan Stilgenbauer; Jiří Mayer; Geoffrey Chan; Ira Gupta; Tina G. Nielsen; Charlotte A. Russell

Book ID: 119218744
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 179 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.05.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoimmunotherapy with O-FC in previous

Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia

✍ Wierda, W. G.; Kipps, T. J.; Durig, J.; Griskevicius, L.; Stilgenbauer, S.; Maye 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 413 KB

5.12 Ofatumumab-Based Chemoimmunotherapy

5.12 Ofatumumab-Based Chemoimmunotherapy for Patients With Previously Untreated Chronic Lymphocytic Leukemia

✍ T. Shanafelt; M. Lanasa; C. Zent C; J. Leis; T. Call; B. LaPlant B; H. Tun; D. B 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 89 KB

Chemoimmunotherapy With Low-Dose Fludara

Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia

✍ Foon, K. A.; Boyiadzis, M.; Land, S. R.; Marks, S.; Raptis, A.; Pietragallo, L.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 106 KB

Chemoimmunotherapy with modified dosing

Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia

✍ Nicole Lamanna; Mark A. Weiss 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 164 KB

Ofatumumab Combined With Fludarabine and

Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial

✍ William G. Wierda; Thomas J. Kipps; Jan Dürig; Laimonas Griskevicius; Stephan St 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 70 KB

PCN71 COST-EFFECTIVENESS OF RITUXIMAB CO

PCN71 COST-EFFECTIVENESS OF RITUXIMAB COMBINED WITH FLUDARABINE AND CYCLOPHOSPHAMIDE IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN FRANCE

✍ M Roussel; X Troussard; A Delmer; M Poinso; H Miadi-Fargier 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB